Please provide your email address to receive an email when new articles are posted on . TAVR was superior to clinical surveillance in patients with asymptomatic severe aortic stenosis. Almost all ...

Medtronic (NYSE: MDT) today announced the launch of its Stedi extra support guidewire for use with its Evolut TAVR platform.

Please provide your email address to receive an email when new articles are posted on . In patients with severe aortic stenosis and obesity, TAVR conferred lower rates of in-hospital mortality and ...

Early transcatheter aortic valve replacement bests clinical surveillance for reducing death, stroke, unplanned hospitalization. HealthDay News — Early transcatheter aortic valve replacement (TAVR) is ...

Lansing resident Sandra Mosier, 75, has lived with a heart murmur her entire life. When she heard the transcatheter aortic valve replacement (TAVR) procedure was now available at McLaren Greater ...

IRVINE, Calif.--(BUSINESS WIRE)-- Edwards Lifesciences (EW) announced today that the U.S. Food and Drug Administration (FDA) has approved its transcatheter aortic valve replacement (TAVR) therapy, the ...

WASHINGTON, DC – New data from a landmark clinical trial found that after five years, transcatheter aortic valve replacement (TAVR) demonstrated a persistent mortality benefit, improved functional ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Transcatheter ...

DUBLIN, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Evolut™ Transcatheter Aortic Valve Replacement (TAVR) system ...

Aortic Stenosis is the most common valvular abnormality among adults, with more than 200,000 cases per year across the United States. The prevalence increases with age, and most often it occurs in men ...